Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5524057 | 0.94 | POLB (0.40) | MEN1KMT2APOLBTSHR | |
| SCHEMBL5519055 | 0.91 | POLB (0.35) | MEN1KMT2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5530960 | 0.87 | MEN1 (0.33) | MEN1KMT2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5519049 | 0.86 | POLB (0.44) | MEN1KMT2APOLBCETPTSHR | |
| SCHEMBL2381368 | 0.84 | CYP3A4 (0.34) | MEN1KMT2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5530957 | 0.82 | POLB (0.38) | MEN1KMT2APOLBTSHR | |
| SCHEMBL5515717 | 0.80 | GAA (0.35) | MEN1KMT2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2381371 | 0.79 | PEPD (0.33) | CYP3A4 | |
| SCHEMBL8529859 | 0.78 | ALDH1A1 (0.39) | MEN1KMT2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5515711 | 0.76 | ALDH1A1 (0.35) | MEN1KMT2APOLBGAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7282601-B2 | Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2007-10-16 | — | — | US | disclosed |
| US-20050038283-A1 | Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester | NEW JAPAN CHEMICAL, CO., LTD. (JP) | 2005-02-17 | — | — | US | disclosed |
| EP-1227078-A1 | DICARBOXYLIC DIESTER, PROCESS FOR PRODUCING THE SAME, AND REFRIGERATING MACHINE LUBRICATING OIL COMPRISING THE ESTER | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2002-07-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038283-A1 | Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester | SCO2, PDHX, DECR2 | MEN1 4282/4885KMT2A 1093/4885CYP1A2 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.